Governors in U.S. states hardest hit by the novel coronavirus sparred with President Donald Trump over his claims they have enough tests and should quickly reopen their economies as more protests are planned over the extension of stay-at-home orders.
As some U.S. states look to start reopening their coronavirus-battered economies amid protests from supporters of President Donald Trump anxious to get back to work, hardest hit New York state began mandating the wearing of masks or face coverings in public to contain the pathogen’s spread.
Ford Motor Co. will produce 50,000 ventilators over a 100-day period at a plant in Michigan in cooperation with General Electric’s healthcare unit, and can then build 30,000 per month as needed to treat patients afflicted with the coronavirus.
U.S. states pleaded with the Trump administration to coordinate a national response to the coronavirus outbreak, saying patchwork measures enacted by state and local authorities were insufficient to confront the coast-to-coast emergency.
U.S. Vice President Mike Pence promised that Americans would have access in the days ahead to more than 2,000 laboratories capable of processing coronavirus tests, and a leading expert said the country would launch a new phase of testing for the fast-spreading disease.
The United States is preparing for thousands of new coronavirus cases and will ask Americans returning from abroad to go into “self-quarantine” for 14 days as part of the effort to contain the outbreak, Vice President Mike Pence said.
On the same day the White House tapped Vice President Mike Pence to lead the government response to the coronavirus, the Biotechnology Innovation Organization (BIO) tapped George Scangos to head up its own response to the outbreak, which causes the COVID-19 disease.
Gilead Sciences lost yet another challenge to the company’s U.S. patent to Truvada for HIV prevention, or PrEP.
China’s National Health Commission stated today that the coronavirus has infected 5,974 individuals, resulting in 132 deaths and 103 people being cured.
The Trump administration, via the Department of Health and Human Services (HHS), filed a lawsuit against Gilead Sciences over Truvada for HIV prevention.